PL343634A1 - Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine - Google Patents

Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Info

Publication number
PL343634A1
PL343634A1 PL99343634A PL34363499A PL343634A1 PL 343634 A1 PL343634 A1 PL 343634A1 PL 99343634 A PL99343634 A PL 99343634A PL 34363499 A PL34363499 A PL 34363499A PL 343634 A1 PL343634 A1 PL 343634A1
Authority
PL
Poland
Prior art keywords
acetylglucosamine
treatment
composition
inflammatory bowel
bowel disease
Prior art date
Application number
PL99343634A
Other languages
English (en)
Inventor
Simon Murch
Ian W French
Original Assignee
Glucogenics Pharmaceuticals In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glucogenics Pharmaceuticals In filed Critical Glucogenics Pharmaceuticals In
Publication of PL343634A1 publication Critical patent/PL343634A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
PL99343634A 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine PL343634A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002234936A CA2234936C (en) 1998-04-17 1998-04-17 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Publications (1)

Publication Number Publication Date
PL343634A1 true PL343634A1 (en) 2001-08-27

Family

ID=4162337

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99343634A PL343634A1 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Country Status (8)

Country Link
EP (1) EP1071432A1 (no)
JP (1) JP2002512195A (no)
CA (1) CA2234936C (no)
CZ (1) CZ20003846A3 (no)
HU (1) HUP0101514A3 (no)
IL (1) IL139072A0 (no)
NO (1) NO20005223L (no)
PL (1) PL343634A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2918452T3 (es) 2007-02-19 2022-07-15 Marine Polymer Tech Inc Composiciones hemostáticas y regímenes terapéuticos
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
WO2011130646A1 (en) 2010-04-15 2011-10-20 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
JP6144254B2 (ja) 2011-04-15 2017-06-07 マリン ポリマー テクノロジーズ，インコーポレーテッド ポリ−ｎ−アセチルグルコサミンナノファイバを用いた疾患の治療
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
CA2967722A1 (en) * 2014-11-26 2016-06-02 Evonik Rohm Gmbh Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Also Published As

Publication number Publication date
CA2234936A1 (en) 1999-10-17
IL139072A0 (en) 2001-11-25
NO20005223D0 (no) 2000-10-17
NO20005223L (no) 2000-11-20
JP2002512195A (ja) 2002-04-23
EP1071432A1 (en) 2001-01-31
HUP0101514A3 (en) 2003-07-28
CZ20003846A3 (cs) 2002-03-13
CA2234936C (en) 2004-06-29
HUP0101514A2 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
IL132145A (en) Compositions for treating inflammatory bowel disease and uses thereof
EP1581119A4 (en) COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS FOR INFLAMMATORY BOWEL DISEASE
EP1240136A4 (en) USE OF BIOLOGICALLY ACTIVE VITAMIN-D COMPOUNDS FOR THE PREVENTION AND TREATMENT OF INFLAMMABLE INTESTINAL DISEASES
HUP9900950A3 (en) Use of nicotine derivatives for producing pharmaceutical compositions suitable for treating inflammatory bowel disease
EP1578385A4 (en) COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF INFLAMMATORY INTESTINAL DISEASES
IL142929A0 (en) Local delivery of drugs to the colon for local treatment of colonic diseases
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
EP1129217A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DISEASES
EP1119255A4 (en) NEW COMPOSITIONS AND METHOD FOR THE PREVENTION AND TREATMENT OF PROTOCOL DISEASES
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
GB9720797D0 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU6386499A (en) Method and composition for treatment of inflammatory bowel disease
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
PL343634A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
EP1085906A4 (en) ANTIBODIES AGAINST CYTOKINS FOR THE PREVENTION AND TREATMENT OF INFLAMMABLE INTESTINAL DISEASES
IL147946A0 (en) Treatment of inflammatory or malignant disease using dnazymes
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
HUP9900309A3 (en) Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
EP1107778A4 (en) TREATMENT OF DISEASE CONDITIONS
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states